Rättskällor med officiella primärkällor

Utskrivet ·

Skip to main content
Skip to the answer
ExploreWorldAIExploreWorldAI

Back to the decisions

Court of Justice of the European Union · Judgment

C‑310/13Novo Nordisk Pharma GmbH v S

Decided
2014-11-20
ECLI
ECLI:EU:C:2014:2385
CELEX
62013CJ0310
Finality
Final, the decision cannot be appealed

The court's own keywords

Reference for a preliminary ruling — Directive 85/374/EEC — Consumer protection — Liability for defective products — Material scope of the directive — Special liability system existing on the date of notification of that directive — Permissibility of a national liability system enabling information on the adverse effects of pharmaceutical products to be obtained.

Interprets

EUR-LexThe Court

Read from EU:s publikationsbyrå, Cellar (EUR-Lex och CURIA) on 2026-08-22.

The row repeats what the source states. It is not a summary, not a conclusion about any single case and not legal advice.

Verifiable trust signals

  • Six fixed blocks, one source per line
  • No sentence written by a language model
  • Engine version and read date on every answer
  • No customer data, no documents, no advice
  • Model card and audit published under the EU AI Act

Model cardAudit